Tech isn’t the only sector receiving billions in venture capital funding. Healthcare and life sciences companies raised more than $8B from VC firms in 2014. And while tech exits may have slowed down, exits of VC-baked healthcare startups have been strong, especially IPOs: there were 61 in 2014 alone.
As VC dollars continue to flow into healthcare, we used CB Insights’ database to identify VC-backed companies treating conditions and diseases affecting different parts of the body.
The companies on our list market a wide range of therapies, drugs, and devices. Thrasos Therapeutics, a biotherapeutics company, works on the prevention and treatment of kidney disease, while Cerecor, a biopharmaceutical company, develops drugs to target neurological and psychiatric disorders. In the medical-device category, some companies are focused on diagnostics while others work on treatment. Humedics, for example, tests liver function via a breath test. SynCardia treats biventricular heart failure with a “Total Artificial Heart,” which helps patients bridge the time to a heart transplant.
Below is a full diagram detailing some of the VC-backed healthcare startups and the major organs or body systems they target:
Want more data on healthcare companies? Check out our venture capital database below.
If you aren’t already a client, sign up for a free trial to learn more about our platform.